1,500+ RA patients join quest for better treatment predictors
NCT ID NCT01793103
First seen Sep 30, 2025 · Last updated Apr 24, 2026 · Updated 22 times
Summary
This study follows about 1,600 adults with rheumatoid arthritis (RA) over time to learn which biological markers can predict how well a drug will work or cause side effects. Researchers also aim to identify markers that show how the disease will progress. Participants receive their usual care while providing data and samples, helping doctors better tailor treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.